November 30, 2024 - 15:12

MARIETTA — Memorial Health System has announced the addition of Dr. Albeir Mousa, a highly qualified vascular surgeon, to its team at Marietta Memorial Hospital. Dr. Mousa brings a wealth of experience and expertise, enhancing the capabilities of the vascular team at MHS. His arrival is expected to significantly improve the level of care available to patients in the region.
Dr. Mousa is known for his proficiency in innovative vascular technologies and research, which will be instrumental in optimizing patient outcomes. His commitment to providing the highest quality of care aligns with the mission of Memorial Health System to deliver exceptional healthcare services to the community.
As he begins seeing patients, Dr. Mousa is poised to make a positive impact on the local healthcare landscape, ensuring that individuals in need of vascular care have access to the latest advancements and treatments available. The integration of his skills into the MHS team marks a promising development for patient care in the area.
August 26, 2026 - 02:33
Faulkner University Awarded More Than $3 Million to Transform Rural Health Care Access and Workforce Development in AlabamaFaulkner University has secured more than $3 million in funding through Alabama`s Rural Health Transformation Program to expand medical services and train a new generation of health care workers...
August 25, 2026 - 13:39
Drug mix-up at Ascension impacts at least 4 surgeries, leaves 1 patient paralyzedHospital officials are working to determine how a contaminated anesthetic may have reached operating rooms, after at least four joint replacement procedures were impacted and one patient was left...
August 24, 2026 - 17:16
Alfalfa sprouts linked to food poisoning in 15 states, officials sayFederal health authorities have identified alfalfa sprouts as the likely source of a multi-state food poisoning outbreak that has now reached 15 states. The Centers for Disease Control and...
August 24, 2026 - 15:42
FDA digital health leader promises generative AI regulatory guidance is comingThe U.S. Food and Drug Administration is preparing to release formal guidance on how it will regulate generative artificial intelligence used in medical devices, according to Rick Abramson, the...